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UNDERSTANDING CHILDREN’S PREFERENCES FOR INFLUENZA 
VACCINES USING CONJOINT ANALYSIS
Flood EM1, Rousculp MD2, Divino VM1, Ryan KJ2, Toback SL2, Hall MC3, Block SL4, 
Mahadevia PJ2
1Oxford Outcomes, Inc., Bethesda, MD, USA, 2MedImmune, Gaithersburg, MD, USA, 
3Marshﬁeld Center, Marshﬁeld, WI, USA, 4University of Louisville, Bardstown, KY, KY, USA
OBJECTIVES: To determine children’s ability to understand and complete conjoint 
questions and assess preferences for inﬂuenza vaccine attributes using conjoint analy-
sis. METHODS: 544 children aged 8–12 years from a nationally representative US 
sample selected from a standing panel completed an online conjoint survey asking 
respondents to choose between two hypothetical inﬂuenza vaccines. Vaccines varied 
based on 4 attributes: vaccine efﬁcacy (works very well, works well), chance of sore 
arm (low, none), chance of runny/stuffy nose (low, none), and mode of administration 
(shot, nose spray). Three questions were included to identify children with difﬁculty 
understanding conjoint questions; those who answered at least one question incor-
rectly were excluded. Analyses were performed using Hierarchical Bayes and included 
estimating the utility for each attribute level and the relative importance (RI) of each 
attribute. RESULTS: 464 (85%) respondents understood the conjoint questions and 
were included in the analysis. Administration mode was the main driver of preference 
(RI = 41%), followed by efﬁcacy (RI = 31%), sore arm (RI = 14%), and runny/stuffy 
nose (RI = 14%). Mode was more important for younger (aged 8–10) vs. older (aged 
11–12) children (RI 43% vs. 37%), while efﬁcacy was more important for older vs. 
younger children (RI 33% vs. 29%). When presented with proﬁles representative of 
available inﬂuenza vaccines, 79% of children chose the live attenuated inﬂuenza 
vaccine (works very well, no chance of sore arm, low chance of runny/stuffy nose, 
nose spray) over the inactivated injectable vaccine (works well, low chance of sore 
arm, no chance of runny/stuffy nose, shot) CONCLUSIONS: Most children aged ≥8 
can make decisions based on attribute trade-offs. Intranasal administration followed 
by high efﬁcacy are the primary drivers for children’s preference of inﬂuenza vaccines. 
Health care providers and parents should involve children ≥8 years in discussions 
regarding their preferred inﬂuenza vaccine, particularly regarding efﬁcacy, side effects 
and mode.
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DRG-BASED HOSPITAL PAYMENT SYSTEM IMPACT ON MEDICAL 
DECISION MAKING
Khalil Y
U. of LOuisville, Louisville, KY, USA
OBJECTIVES: The Inpatient Prospective Payment System (IPPS) is a payment system 
for service costs; each case is categorized by the diagnosis-related group (DRG). DRGs 
facilitate efﬁcient allocation of hospitals resources, yet alternatively raises concerns in 
relation to services provision. The main objective of this work is to investigate the 
impact of using the DRG billing system on medical decision making and service quality 
in terms of length of stay (LOS), total number of diagnoses (NDX) and total number 
of ICD-9-CM procedures (NPR). METHODS: The dataset used was obtained from 
the Nationwide Inpatient Sample (NIS) for 2005, which contains clinical and resource 
use information included in a typical discharge abstract, with safeguards to protect 
the privacy of individual patients, physicians, and hospitals. This study included 
patients from all ages who were admitted to the hospital with an initial diagnosis of 
seasonal ﬂu. Kernel Density Estimation (KDE) was used to investigate the variation 
on LOS, NDX, and NPR for the same DRG; several DRGs values (89, 68 and 70) 
were used to deﬁne provided services. In addition, LOS values were clustered to 
illustrate the dissimilarity within the same DRG class. RESULTS: Out of 24,348 
patients, 14% were diagnosed with “Simple Pneumonia”, 13% “Otitis Media & 
Upper Respiratory Infection, age > 17”, 13% with “Otitis Media & Upper Respiratory 
Infection, age<17”. Also, 16.87% had diabetes and 1.6% died during hospitalization. 
The KDE showed considerable variation in LOS, NDX and NPR values for the same 
DRG “89”. Least Squares criteria were used to cluster LOS for DRG “89,” which 
resulted in 4 clusters. CONCLUSIONS: A strong variation between the length of stay, 
number of diagnoses and procedures for the same DRG class emphasize the need to 
reform the inpatient prospective payment system (IPPS) to avoid service provision, 
improve hospital’s resources utilization, and reduce service costs.
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MENINGITIS VACCINE COVERAGE AND ADOPTION ACROSS THE 
UNITED STATES
Doyle J, Baumgartner J, Bell J
Quintiles Global Consulting, Hawthorne, NY, USA
OBJECTIVES: To evaluate coverage of the Meningitis vaccine and explore explana-
tions for variation across the United States. Meningitis vaccination rates vary signiﬁ-
cantly by state from 12% to 65% for children 13–17 years. The CDC recommends 
vaccination after 11 years of age while state legislation ranges from vaccination 
requirements to public health education initiatives for post secondary or college-bound 
students. METHODS: Study included analysis of CDC vaccination rates, Census data 
and State Legislations. Health care system and socioeconomic characteristics were 
identiﬁed and evaluated with respect to meningitis vaccine coverage. Meningitis state 
legislations were valued on a scale of 1–4 (1 deﬁned as no requirement and 4 deﬁned 
as vaccine required with only exemptions allowed). Regression models were run on 
each state-level variable separately, then independent predictor variables were identi-
ﬁed and run in a multi-variable model to evaluate coverage rate variation. RESULTS: 
The correlation between meningitis vaccination rates and the following variables: 
pediatricians per 1000 state inhabitants, the enactment of state legislation require-
ments, and state poverty rate yielded R2 values of 0.31, 0.06, and 0.03, respectively. 
When variables were combined in a multi-variable regression, the model suggested an 
R2 value of 0.35 and an f-value of 8.4. We found a positive correlation between the 
percentage of people who graduated college and vaccination rates (R2 values 0.26 and 
f-value of 17.5), while high school graduation rates did not correlate with vaccination 
rates. CONCLUSIONS: Pediatrician access and college education appear to be predic-
tive of meningitis vaccination rates by state, while state legislation may not result in 
a higher vaccination rate. More research is required to focus public health intervention 
on the operative levers to improve vaccine coverage.
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UNINFECTED CHILDREN OF HIV-INFECTED AND UNINFECTED 
PARENT(S): A COMPARATIVE ANALYSIS OF HEALTH CARE 
UTILIZATION AND HEALTH STATUS
Ganguli A1, Gourley D2, White-Means S2, Evans T3, Wang J4, Dorko C5
1University of Tennessee Health Science Center, Memphis, TN, USA, 2University of 
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OBJECTIVES: Increased life expectancy of HIV-infected individuals has lead to an 
increase in number of uninfected children living with their HIV-infected parent(s). 
This study investigated the health care utilization and health status of these uninfected 
children. METHODS: In a cross-sectional matched case-control analysis, health care 
utilization and health status were compared between uninfected children (2 yrs-15 yrs) 
currently residing with- HIV-infected parent(s) (parent group) and HIV-negative 
parents (comparison group). HIV-infected parents provided information on the parent 
group (face-to-face interview). A representative sample from MEPS-2006 database 
provided information on the comparison group. HIV-infected parent were those with 
a prior diagnosis of HIV/AIDS (ICD-9-CM 042, 043, V08). Each child from the parent 
group was matched with two children in the comparison group (1:2 ratio) using 
propensity score technique. Multivariable logistic and negative-binomial regressions 
were conducted to control for patient-related and parent-related characteristics. 
RESULTS: Upon matching, 89 children living with HIV-infected parent(s) matched 
with 178 children of HIV uninfected parents. Both groups were similar in their demo-
graphic and socio-economic characteristics including parents’ health insurance status. 
Children of HIV-infected parent(s) were 1.682 times (95% CI: 1.115–6.453) more 
likely to have a doctor visit and had 49% (p = 0.0206) more doctor visits than com-
parative group. The parent group had 3.0 times more hospital visits (p = 0.0244) and 
86% more emergency room visits (p = 0.0464) compared to comparison group. 
Though the parent group showed no difference in their school/daycare absenteeism, 
they were 4.041 times more likely (95% CI: 1.887–13.471) to be overweight and 
5.520 times more likely to be on a psychotropic medication (95% CI: 1.503–20.276) 
compared to comparison group. CONCLUSIONS: This study found children living 
with their HIV infected parent(s) had higher health care utilization and compromised 
health status, especially mental health, compared to those living with HIV-negative 
parents. Long term impacts of the study ﬁndings needs to be further investigated.
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POLYMORBIDITY, THERAPY AND COSTS OF AMBULATORY CARE FOR 
HEPATITIS C PATIENTS IN GERMANY
Biteeva I, Schreder H, Sindern J, Rudolph I
Janssen-Cilag GmbH, Neuss, Germany
OBJECTIVES: Hepatitis C virus (HCV) infection is an emerging problem in public 
health. The purpose was to analyze retention-rates of patients on therapy for HCV 
with Peginterferon alfa-2b or alfa-2a (pegINF) and Ribavirin (RBV), number of 
consultations of patients on therapy and after discontinuation, hospitalization-rates, 
co-medication, co-diagnoses and cost of therapy in Germany. METHODS: Retrospec-
tive longitudinal aggregated patient data from the IMS Disease Analyzer was used. 
Patients with at least one diagnosis of HCV (ICD 10: B17.1 HCV acute and/or B18.2 
HCV chronic) within 2006 and 2007 were included. To follow up a full course of 
therapy, patients on treatment with RBV/ pegINF within period Q2/2006–Q4/2007 
were analyzed. Starting with the ﬁrst concomitant prescription of RBV/pegINF every 
patient was followed for 48 weeks. RESULTS: 5.755 patients seen by GPs had an 
HCV-diagnosis within 2006–2007. Out of these patients 196 (4%) received combina-
tion therapy (RBV/pegINF). 102 patients started therapy from Q2/2006 till Q4/2007 
and were included in analysis. Just ¼ of patients stay on therapy for full 48 weeks. 
Costs of HCV medication per patient on therapy varies from 3 5.791 (ﬁrst quarter) 
to 3 4.146 (fourth quarter). Approximately 30% of patients with diagnosis of HCV 
have mental or behavioral disorders. Most frequent co-medications for HCV-patients 
are aiming at diseases of nervous and digestive system. Polymorbidity in patients with 
HCV is higher than in patients without HCV. CONCLUSIONS: Only 25% of patients 
on therapy receive the treatment for 48 weeks. Potential reasons for discontinuation 
are signiﬁcant adverse effects, which reduce compliance and adherence during the long 
treatment duration. Reduction of therapy duration, doctor and patient education 
could possibly increase the number of patients fulﬁlling a complete course of therapy. 
This could help avoid complications of HCV such as hepatic ﬁbrosis, cirrhosis or 
hepatocellular carcinoma and save lives and overall costs.
